Clinical Trial Update: MGTA-145 + Plerixafor in the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MGTA-145 with plerixafor for mobilization of hematopoietic stem cells in autologous transplantation for multiple myeloma has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• MGTA-145
• Plerixafor (Plerixafor)

Snippet

Sponsor: Surbhi Sidana, MD | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2022-09-10